Literature DB >> 17495243

Thymosin beta4 is not always the main beta-thymosin in mammalian platelets.

Thomas Huff1, Christian S G Müller, Ewald Hannappel.   

Abstract

beta-thymosins constitute a family of highly conserved 5-kDa polypeptides. Thymosin beta(4), the most abundant member of this family, is expressed in most mammalian cell types and is regarded as the main intracellular G-actin sequestering peptide. In addition to this important intracellular function several other activities have been attributed to this peptide. Thymosin beta(4) is released from human platelets and cross-linked to fibrin after activation of platelets with thrombin. While in most mammalian tissues thymosin beta(4) is accompanied by a second member of this peptide family, in human platelets only thymosin beta(4) is present. To elucidate if it is common to mammalian platelets that only one beta-thymosin is present, we analyzed platelets from several mammals for their beta-thymosin content. In human platelets only thymosin beta(4) could be detected, whereas in bovine platelets thymosin beta(9), which is normally the minor beta-thymosin in bovine tissues, was identified as the main beta-thymosin. In rabbit platelets, thymosin beta(4) is not simply replaced by the most homologous thymosin beta(4)(Ala), as might be expected from sequence homology. Thymosin beta(4)(Ala) and thymosin beta(10) were found, but thymosin beta(10) is present in about 2.5-fold higher amounts. Because thymosin beta(4)(Ala) possesses about threefold higher affinity to G-actin, compared to thymosin beta(4), beta(10), and beta(9), we suggest that expression of beta-thymosins is triggered by functional requirements and not sequence homology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495243     DOI: 10.1196/annals.1415.029

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  5 in total

Review 1.  Tropomodulins: pointed-end capping proteins that regulate actin filament architecture in diverse cell types.

Authors:  Sawako Yamashiro; David S Gokhin; Sumiko Kimura; Roberta B Nowak; Velia M Fowler
Journal:  Cytoskeleton (Hoboken)       Date:  2012-05-04

2.  Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection.

Authors:  Rabea Hinkel; Chiraz El-Aouni; Tonia Olson; Jan Horstkotte; Stefan Mayer; Sebastian Müller; Michael Willhauck; Christine Spitzweg; Franz-Josef Gildehaus; Wolfgang Münzing; Ewald Hannappel; Ildiko Bock-Marquette; J Michael DiMaio; Antonis K Hatzopoulos; Peter Boekstegers; Christian Kupatt
Journal:  Circulation       Date:  2008-04-21       Impact factor: 29.690

3.  Thymosin β4 increases the potency of transplanted mesenchymal stem cells for myocardial repair.

Authors:  Lei Ye; Pengyuan Zhang; Sue Duval; Liping Su; Qiang Xiong; Jianyi Zhang
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

4.  Chimeric Adeno-Associated Virus-Mediated Cardiovascular Reprogramming for Ischemic Heart Disease.

Authors:  So Young Yoo; Su-Nam Jeong; Jeong-In Kang; Seung-Wuk Lee
Journal:  ACS Omega       Date:  2018-05-31

5.  Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis.

Authors:  Thomas W Carion; Abdul Shukkur Ebrahim; Spandana Alluri; Thanzeela Ebrahim; Tressa Parker; Julia Burns; Gabriel Sosne; Elizabeth A Berger
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.